<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Virginia School of Medicine</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Charlottesville, Virginia, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Medical School</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1819</td>
</tr>
<tr>
<td class="label">Website</td>
<td>med.virginia.edu</td>
</tr>
<tr>
<td class="label">Key Centers</td>
<td>BIG Center, Department of Neuroscience, ADRC</td>
</tr>
</table>
<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">University of Virginia School of Medicine</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Charlottesville, Virginia, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Public Medical School</td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1819</td>
</tr>
<tr>
<td class="label">Website</td>
<td>med.virginia.edu</td>
</tr>
<tr>
<td class="label">Key Centers</td>
<td>BIG Center, Department of Neuroscience, ADRC</td>
</tr>
</table>
The University of Virginia School of Medicine stands as one of the nation's oldest and most prestigious public medical schools. Founded in 1819 by Thomas Jefferson as part of the University of Virginia, the school has evolved from a small regional medical school into a world-class research institution with groundbreaking contributions to understanding neurodegenerative diseases. The school's location in Charlottesville, Virginia, provides a unique environment that combines the resources of a major research university with the collaborative culture of a smaller academic community["@kipnis2016"].
UVA School of Medicine has established itself as a leader in neuroscience research, particularly in the areas of neuroimmunology, microglia biology, and the fundamental mechanisms underlying Alzheimer's and Parkinson's diseases. The establishment of the Center for Brain Immunology and Glia (BIG) has positioned UVA at the forefront of understanding how the immune system interacts with the brain in neurodegeneration. This research has led to paradigm-shifting discoveries, including the identification of the brain's lymphatic system and disease-associated microglia (DAM) that have revolutionized our understanding of how the brain clears waste and responds to pathology["@keren-shaul2017"][@iliff2012].
The school's commitment to interdisciplinary research brings together basic scientists, clinical researchers, and physician-scientists in a collaborative environment that accelerates discovery and translation. With over 1,000 faculty members and state-of-the-art research facilities, UVA School of Medicine continues to make significant contributions to understanding and treating neurodegenerative diseases that affect millions of Americans.
The University of Virginia was founded in 1819 with a vision of creating a university that would provide a unique model of higher education. The medical school, established as part of this vision, was revolutionary for its time in emphasizing practical medical education and clinical experience. Over two centuries later, UVA continues to embody Jefferson's commitment to innovation and excellence in education and research.
The transformation of UVA School of Medicine from a regional medical school to a world-class research institution occurred gradually over the past several decades. Key milestones include:
The Center for Brain Immunology and Glia represents UVA's flagship initiative in neuroimmunology research[@kipnis2016][@werther2020]. This center brings together researchers studying the intersection of immunology and neuroscience, with a particular focus on how immune cells contribute to both normal brain function and neurodegenerative diseases.
Research Focus Areas:
| Area | Description | Faculty |
|------|-------------|---------|
| Microglia Biology | Role of microglia in AD, PD, MS | Kipnis, Butovsky |
| Neuroinflammation | Mechanisms of chronic inflammation | Wyss-Coray |
| Brain-immune Interactions | Lymphatic system, CNS immune privilege | Ajami |
| Therapeutic Development | Targeting neuroinflammation | Various |
Key Discoveries:
The BIG Center has made several landmark discoveries:
The Department of Neuroscience conducts comprehensive research across all aspects of nervous system function:
Research Programs:
UVA has emerged as a leader in understanding the role of neuroinflammation in Alzheimer's disease[@bennett2018][@werther2020]. Rather than viewing inflammation as merely a secondary response to amyloid and tau pathology, UVA researchers have demonstrated that neuroinflammation is a primary driver of disease progression.
Key Research Areas:
Microglia in AD: UVA researchers have pioneered the study of microglia in Alzheimer's disease, demonstrating that these immune cells can both protect and damage the brain depending on their activation state[@golub2017]. The identification of disease-associated microglia (DAM) has revealed new therapeutic targets[@keren-shaul2017].
TREM2 and Microglial Activation: The discovery that TREM2 mutations increase AD risk has led to intensive investigation of microglial activation pathways[@carty2019]. UVA researchers are developing approaches to enhance beneficial microglial functions while inhibiting damaging inflammation.
Complement and Synapse Elimination: Studies on the complement system have revealed how microglia eliminate synapses in AD, providing potential targets for preserving synaptic function[@shi2019].
Beyond neuroinflammation, UVA researchers study the fundamental mechanisms of amyloid and tau pathology:
UVA's Alzheimer's Disease Research Center (ADRC) provides:
UVA researchers investigate the intersection of alpha-synuclein pathology and neuroinflammation in Parkinson's disease:
Research programs focus on:
One of UVA's most significant contributions to neuroscience was the identification of disease-associated microglia (DAM)[@keren-shaul2017]. This work revealed that microglia transition through distinct activation states during neurodegeneration:
Stage 1 (Homeostatic): Resting microglia with surveillance functions
Stage 2 (Intermediate): Early activation with minimal changes
Stage 3 (DAM): Fully activated microglia with:
UVA researchers study how aging affects microglial function[@hammond2019]:
Research demonstrates significant microglial diversity across brain regions and disease states[@hansen2018]:
UVA's discovery of the brain's lymphatic system represents a paradigm shift in understanding brain-immune interactions[@iliff2012][@kipnis2016]. This work revealed that:
Anatomy: Functional lymphatic vessels exist in the dura mater
Function: Cerebrospinal fluid drains through these vessels to cervical lymph nodes
Implications: The brain is not immunologically isolated—it has dedicated pathways for immune cell traffic
This discovery has major implications for understanding:
UVA offers comprehensive training in neuroscience[@steven2018]:
UVA graduates have gone on to leadership positions at:
The UVA ADRC provides:
UVA maintains state-of-the-art research infrastructure[@brown2019]:
UVA researchers utilize:
Dr. Jonathan Kipnis: Pioneered the study of brain-immune interactions and discovered the brain lymphatic system
Dr. Oleg Butovsky: Expert in microglial biology and TREM2 biology
Dr. Kevin Wyss-Coray: Leader in neuroinflammation and aging research
UVA is pursuing several new research directions:
UVA participates in major research consortia:
Collaborations with pharmaceutical companies on: